Harrow Health
HROW
$16.76
Share price
3.71%
Change (1 day)
-22.44%
Change (1 year)
Categories
P/S ratio for Harrow Health (HROW)
P/S ratio as of May 2024 (TTM): 4.39
According to Harrow Health's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.39172. At the end of 2023 the company had a P/S ratio of 3.02.
P/S ratio history for Harrow Health from 2009 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 3.02 | -39.13% |
| 2022 | 4.96 | 54.75% |
| 2021 | 3.21 | -11.27% |
| 2020 | 3.61 | -6.88% |
| 2019 | 3.88 | 15.95% |
| 2018 | 3.35 | 156.73% |
| 2017 | 1.30 | -21.52% |
| 2016 | 1.66 | -76.12% |
| 2015 | 6.96 | -83.36% |
| 2014 | 41.8 | -98.61% |
| 2013 | > 1000 | 356.48% |
| 2012 | 660 | |
| 2011 | N/A | |
| 2010 | N/A | |
| 2009 | N/A |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 1.05 | -76.11% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 92.5 | 2,006.20% | 🇺🇸 USA |